Latest news for Quest PharmaTech (OTC:QPTFF) Stock

Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.

QUEST PHARMATECH INC ORD by Quest PharmaTech, Inc.

Comments

Quest PharmaTech

News

Latest news for Quest PharmaTech (OTC:QPTFF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga